Blog Archives

BÜHLMANN is proud to add Quantum Blue® Anti-Infliximab (RUO) and Quantum Blue® Anti-Adalimumab (RUO) to the TDM rapid test portfolio.

A French medical TV show presented a story about how healthcare professionals and patients are using IBDoc®, the fecal calprotectin home test, to improve their control over the disease.

We announce a new partner channel agreement with Roche Diagnostics for the launch and distribution of the BÜHLMANN fCAL® turbo test.

BÜHLMANN proudly announces the availability of the new turbidimetric assay for the simplified quantification of human pancreatic elastase, the BÜHLMANN fPELA® turbo.